Canbi Pharma Tech Limited
CAS 2050038-81-6 | Abt-494 Intermediate
2050038-81-6 ABT-494 Intermediate
2050038-81-6

CAS 2050038-81-6 | Abt-494 Intermediate

CAS:2050038-81-6
MF:C32H35N5O7S
MW:633.71
EINECS:944-343-2
MDL No.:MFCD33023506

Send Inquiry
Description

Specification:

Appearance White to yellow or brown solid
Purity (HPLC) ≥98.0%
Identification Retention time:Similar to reference substance
Enantionmer ≤0.15%
Loss on drying ≤1.0%(w/w)

 

Storage: Store in a tightly closed container. Keep it in a cool and dry place.(Room temperature)

Package:  500g/bag, 1kg/bag, 25kg per carton or drum, other package depends on demand...

Packing photos:

2050038-81-6 1

 

 

Application:

      This product is an intermediate of Upadacitinib, used for subsequent deprotection, structural modification, and other steps to ultimately obtain the raw material of Upadacitinib.
    (Upadacitinib is a globally renowned targeted drug in the field of rheumatology and immunology, with approved indications including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, moderate to severe atopic dermatitis, ulcerative colitis, Crohn's disease, etc. It has also demonstrated therapeutic potential in clinical studies of immune related diseases such as vitiligo.)

 

 

Route of Synthesis:

product-605-393

Description for Route of Synthesis:

Step 1: C-N Bond Formation (Amination)

   Reactants: 5-(p-toluenesulfonyl)-2-bromo-5H-pyrrolo[2,3-b]pyrazine + ethyl carbamate (EtOOCNH₂)

   Reaction: Nucleophilic aromatic substitution (SNAr)

   Outcome: The bromine on the pyrazine ring is displaced by ethyl carbamate, forming ethyl (5-(p-toluenesulfonyl)-5H-pyrrolo[2,3-b]pyrazin-2-                        yl)carbamate, installing a protected amine at the C2 position of the heterocycle.

Step 2: N-Alkylation (Coupling to Pyrrolidine Scaffold)

   Reactants: Step 1 product + (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylic acid benzyl ester

   Reaction: Deprotonation of the carbamate N-H, followed by nucleophilic attack on the bromoacetyl group of the pyrrolidine substrate, displacing                      bromide.

   Outcome: The heterocyclic intermediate is covalently linked to the chiral pyrrolidine core, yielding the final target compound with full retention of the                   (3R,4S) stereochemistry.

 

 

 

Synonyms:
ABT-494 Intermediate
benzyl (3R,4S)-3-(N-(ethoxycarbonyl)-N-(5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)glycyl)-4-ethylpyrrolidine-1-carboxylate
1-Pyrrolidinecarboxylic acid, 3-[2-[(ethoxycarbonyl)[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-4-ethyl-, phenylmethyl ester, (3R,4S)-

Upadacitinib N-3

Upadacitinib intermediate

 

 

 

Hot Tags: CAS 2050038-81-6 | Abt-494 Intermediate, China CAS 2050038-81-6 | Abt-494 Intermediate manufacturers, suppliers, competitive intermediate, intermediate customized products, 1 Bromo 3 5 dimethoxybenzene, 2-Aminopyrimidine, sales promotion intermediate, intermediate compounds

Inquiry
goTop

(0/10)

clearall